 PLANEGGMUNICH, GERMANY ACCESSWIRE May 14, 2020 MorphoSys AG FSE:MOR; Prime Standard Segment; MDAX TecDAX; NASDAQ:MOR announced today that multiple abstracts from the Companys tafasitamab program ... 